IL-33−/− mice demonstrated significantly less weight loss during lethal infection with O. tsutsugamushi, and exogenous recombinant IL-33 treatment had exacerbated disease following sublethal infection (Shelite et al., 2016). The gene discussed is IL33; the disease is infection.